Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Botox injection for post-PAO hip pain
2019-004488-33Phase 4Completed
- Sponsor
- Niels Bang
- Start
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in hip dysplasia (DDH) and postoperative hip pain, sponsored by Niels Bang. Primary endpoint: Change in hip pain on VAS. Started Dec 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hip dysplasia (DDH)postoperative hip pain
Beyond the preview
Go deeper on 2019-004488-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004488-33.